Peter Bach - Concepedia

Author

Peter Bach

AstraZeneca (Sweden)

Also Known As

Bach, Peter, Peter Bach

Publications

650

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (Sweden)AstraZeneca (Australia)Aarhus University Arrien Pharmaceuticals (United States)

About

Peter Bach is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	310
2	Natural Sciences	3	3	104
3	Engineering	2	2	67
4	Social Sciences	1	1	23
5	Anesthesia	1	1	69

Peter Bach

Publications

604

Citations

H-Index

Page 1

	Year	Citations
A Comparison of Electrophysiologically Guided Antiarrhythmic Drug Therapy with Beta-Blocker Therapy in Patients with Symptomatic, Sustained Ventricular Tachyarrhythmias Gerhard Steinbeck, Dietrich Andresen, Peter Bach, New England Journal of Medicine	1992	185
Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: Evaluation by programmed stimulation and ambulatory electrocardiogram Gerhard Steinbeck, Peter Bach, Ralph Haberl Journal of the American College of Cardiology Sustained Ventricular TachyarrhythmiasElectrophysiological EvaluationOral SotalolElectrophysiologyProgrammed Stimulation	1986	69
Lead Optimization of Ethyl 6-Aminonicotinate Acyl Sulfonamides as Antagonists of the P2Y<sub>12</sub> Receptor. Separation of the Antithrombotic Effect and Bleeding for Candidate Drug AZD1283 Peter Bach, Thomas Antonsson, Ruth Bylund, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyPharmaceutical ChemistryAntithrombotic EffectPharmacodynamic Modeling	2013	63
Influence of Lewis Acid and Solvent in the Hydrosilylation of Aldehydes and Ketones with Et<sub>3</sub>SiH; Tris(pentafluorophenyl)borane B(C<sub>6</sub>F<sub>5</sub>)<sub>3</sub> versus Metal Triflates [M(OTf)<sub>3</sub>; M = Sc, Bi, Ga, and Al] – Mechanistic Implications Peter Bach, Andrea Albright, Kenneth K. Laali European Journal of Organic Chemistry Chemical EngineeringEngineeringLewis AcidHigh ChemoselectivityOrganometallic Electrochemistry	2009	48
Synthesis, structure–property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y12 receptor Peter Bach, Jonas Boström, Kay Brickmann, European Journal of Medicinal Chemistry Molecular PharmacologyPharmaceutical ScienceBiochemistryMedicineP2y12 Receptor	2013	42
A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor Peter Bach, Jonas Boström, Kay Brickmann, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyNovel SeriesBiochemistryMedicinePhysiology	2011	32
A new series of pyridinyl-alkynes as antagonists of the metabotropic glutamate receptor 5 (mGluR5) Peter Bach, Karolina Nilsson, Andreas Wållberg, Bioorganic & Medicinal Chemistry Letters BiochemistryFunctional SelectivityMedicineMechanism Of ActionNeuropeptide Receptor	2006	31
Synthesis of an 1-azaglucose analogue with ring-oxygen retained Peter Bach, Mikael Bols Tetrahedron Letters Pharmacology1-Azaglucose AnalogueNatural Product Synthesis	1999	28
Warming of patients with accidental hypothermia using warm water pleural lavage Benedict Kjærgaard, Peter Bach Resuscitation HyperthermiaThermal TherapyEmergency MedicineMedicineAccidental Hypothermia	2005	28
Metabotropic glutamate receptor 5 modulators and their potential therapeutic applications Peter Bach, Methvin Isaac, Abdelmalik Slassi Expert Opinion on Therapeutic Patents Potential Therapeutic ApplicationsSynaptic TransmissionNeurotransmitterGlutamate ReceptorsSocial Sciences	2007	23

Page 1